Clinical Validation of New Breathing Sensors in Patients With Respiratory Insufficiency
NXT_SLEEP
NXT_SLEEP: the Development of a Next Generation Sleep Monitoring Platform
1 other identifier
interventional
28
1 country
1
Brief Summary
The NXT\_SLEEP study, bringing together industry partners, research groups and (home) care providers, tackles will develop a next generation sleep-monitoring platform that consists of less obtrusive sensors, and that delivers complete and useful information regarding the physiological parameters relevant for sleep-related breathing disorders. These new and innovative sensors need to be validated in a clinical setting where they will be benchmarked with the classical sleep monitoring systems. In order to compare the novel sensors with the classical monitoring system, the investigators use existing technologies that capture simultaneously the acquired signals of different physiological parameters relevant for sleep-related breathing disorders.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2013
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2013
CompletedFirst Submitted
Initial submission to the registry
July 8, 2013
CompletedFirst Posted
Study publicly available on registry
July 22, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2014
CompletedMay 28, 2015
May 1, 2015
1.5 years
July 8, 2013
May 27, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in breathing pattern during sleep by a movement sensor
New innovative sensors will measure breathing pattern during the night, simultaneously with the classical monitoring systems in order to validate the new sensors.
During 5 nights
Secondary Outcomes (2)
Change in ECG
During 5 nights
Change in end tidal carbon dioxide fraction
During 5 nights
Study Arms (1)
Sensor testing and validation
OTHERInterventions
Eligibility Criteria
You may qualify if:
- Patients who are hospitalized for their respiratory disease
- Written informed consent obtained
You may not qualify if:
- Patients with an uncontrolled disease or any condition that might, in the judgement of the investigator, place the patient at undue risk or potentially comprise the results of interpretation of the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Antwerplead
- iMindscollaborator
Study Sites (1)
University Hospital Antwerp
Edegem, Antwerp, 2650, Belgium
Study Officials
- PRINCIPAL INVESTIGATOR
Wilfried De Backer, MD, PhD
University Hospital, Antwerp
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD PhD
Study Record Dates
First Submitted
July 8, 2013
First Posted
July 22, 2013
Study Start
June 1, 2013
Primary Completion
December 1, 2014
Study Completion
December 1, 2014
Last Updated
May 28, 2015
Record last verified: 2015-05